Paper Details

  1. Home
  2. Paper Details

[Evaluation of tolerance of zidovudine-lamivudine-nevirapine combination in HIV 1 patients in Fann Teaching Hospital in Dakar].

Author: BentalebH, CisseV M P, Dia BadianeN M, DiengA B, DiopB M, DiopS A, DioufA, Fortes DéguénonvoL, KaD, LakheN A, LeyeM M M, MangaM N, NdourC T, SeydiM, SoumaréM, SowP S

English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study evaluated the tolerance of the zidovudine (AZT), lamivudine (3TC), and nevirapine (NVP) combination regimen in HIV-1 patients. The study found that two-thirds of patients experienced at least one side effect, with digestive disorders and neuropsychiatric symptoms being the most common. Most of the side effects were minor, but the clinical and biological tolerance of the treatment should be monitored throughout the follow-up period.
Paper Details　
Original Abstract of the Article :
We conducted a study to evaluate the tolerance of the zidovudine (AZT), lamivudine (3TC) and nevirapine (NVP) combination regimen in HIV-1 patients by a descriptive analytical retrospective study of all HIV-1 patients receiving AZT-3TC-NVP combination between 2008 and 2011. Seventy patients were inc...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s13149-013-0315-8

データ提供：米国国立医学図書館（NLM）

Evaluation of Zidovudine-Lamivudine-Nevirapine Combination in HIV-1 Patients

This study evaluates the tolerance of the zidovudine (AZT), lamivudine (3TC), and nevirapine (NVP) combination regimen in treating HIV-1 patients. The researchers retrospectively reviewed the medical records of patients receiving this regimen and found that while most side effects were minor, digestive disorders and neuropsychiatric symptoms were common. The study highlights the importance of monitoring for potential side effects during treatment with this drug combination.

Managing Side Effects in HIV Treatment

The study provides valuable information regarding the tolerance of the zidovudine (AZT), lamivudine (3TC), and nevirapine (NVP) combination regimen in treating HIV-1 patients. The researchers found that while most side effects were minor, digestive disorders and neuropsychiatric symptoms were common. This information highlights the importance of monitoring for potential side effects during treatment with this drug combination and emphasizes the need for close patient follow-up.

Navigating the Challenges of HIV Treatment

Imagine a camel traversing a harsh desert landscape, facing the challenges of heat, thirst, and potential dangers. Just as the camel relies on its strength and resilience to overcome these obstacles, individuals with HIV need effective treatments and vigilant monitoring to manage their condition. This study emphasizes the importance of understanding potential side effects associated with HIV treatment and the need for close patient follow-up to ensure optimal health outcomes.

Dr.Camel's Conclusion

This study provides valuable insights into the tolerance of the zidovudine (AZT), lamivudine (3TC), and nevirapine (NVP) combination regimen in treating HIV-1 patients. While most side effects are minor, the study highlights the importance of monitoring for potential adverse effects, particularly digestive disorders and neuropsychiatric symptoms. This information is crucial for healthcare providers and patients to ensure optimal treatment outcomes and a high quality of life for individuals with HIV.
Date :
  1. Date Completed 2014-07-01
  2. Date Revised 2013-11-01
Further Info :

Pubmed ID

24150730

DOI: Digital Object Identifier

10.1007/s13149-013-0315-8

SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.